m6A-centered Crosstalk Information

Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
Crosstalk ID
M6ACROT05769
 [1]
m6A modification Circ_PRKAR1B Circ_PRKAR1B METTL3 Methylation : m6A sites Direct Enhancement Non-coding RNA circPRKAR1B SPTBN1  lncRNA       miRNA   circRNA
m6A Modification:
m6A Regulator Methyltransferase-like 3 (METTL3) WRITER
 Regulator Info 
m6A Target Circ_PRKAR1B
 Targert Gene 
Epigenetic Regulation that have Cross-talk with This m6A Modification:
Epigenetic Regulation Type Non-coding RNA (ncRNA)
Epigenetic Regulator Circ_PRKAR1B circRNA View Details
Regulated Target Spectrin beta, non-erythrocytic 1 (SPTBN1) View Details
Crosstalk Relationship m6A  →  ncRNA Enhancement
Crosstalk Mechanism m6A regulators directly modulate the functionality of ncRNAs through specific targeting ncRNA
Crosstalk Summary METTL3-mediated m6 A modification of Circ_PRKAR1B promotes Crohn's colitis by by interacting with Spectrin beta, non-erythrocytic 1 (SPTBN1).
Responsed Disease Crohn disease ICD-11: DD70.3
 Disease Info 
Pathway Response Autophagy hsa04140
Cell Process Pyroptosis
Cell autophagy
In-vitro Model
 NCM460 Normal Homo sapiens CVCL_0460
HCoEpiC (Healthy colon epithelial HCoEpiC cells)
In-vivo Model Twelve-week-old wild-type (WT) and IL-10-KO mice were allocated randomly to four groups (n = 5 per group): (1) the WT group; (2) the IL-10 KO + si-control group (administrated saline as a placebo via enema once); (3) the IL-10 KO + si-circPRKAR1B group (administrated 200 μL of 1e11 vg adeno-associated virus (AAV) vector carrying si-circPRKAR1B via enema once); and (4) the IL-10 KO + si-METTL3 group (administrated 200 μL of 1e11 vg AAV vector carrying si-METTL3 via enema once).
Full List of Potential Compound(s) Related to This m6A-centered Crosstalk
Spectrin beta, non-erythrocytic 1 (SPTBN1) 1 Compound(s) Regulating the Target Click to Show/Hide the Full List
 Compound Name ABT-413 Phase 1 [2]
External Link
TTD: D01QKZ
DD70: Crohn disease 265 Compound(s) Regulating the Disease Click to Show/Hide the Full List
 Compound Name Natalizumab Approved [3]
External Link
TTD: D3LWJ7
 Compound Name Clofazimine Approved [4]
Synonyms
2030-63-9; Lamprene; Lampren; Chlofazimine; Clofazimina; Clofaziminum; Clofaziminum [INN-Latin]; B 663 (Pharmaceutical); Clofazimina [INN-Spanish]; B-663; NSC-141046; G 30320; UNII-D959AE5USF; B 663 (VAN); C27H22Cl2N4; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin; B 663; 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine; EINECS 217-980-2; CFZ; SMP2_000339; B 663, pharmaceutical; G-30320; Lamprene (TN); Liposome-encapsulated clofazimine; Clofazimine [USAN:INN:BAN]; G-30,320; Clofazimine (JAN/USP/INN); N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine; N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine; N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine; (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine; 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine; 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]; Riminophenazine
    Click to Show/Hide
External Link
CID: 2794
TTD: D0S5UH
DrugBank: DB00845
 Compound Name MLN0002 Approved [5]
Synonyms
Vedolizumab
    Click to Show/Hide
External Link
TTD: D0PK5M
 Compound Name Vedolizmab Approved [6]
Synonyms
4168-17-6
    Click to Show/Hide
External Link
TTD: D0N5ZS
 Compound Name Metronidazole Phase 3 [7]
Synonyms
APMN; Acromona; Anagiardil; Arilin; Atrivyl; Bexon; CONT; Clont; Danizol; Deflamon; Efloran; Elyzol; Entizol; Eumin; Flagemona; Flagesol; Flagil; Flagyl; Flegyl; Florazole; Fossyol; Giatricol; Gineflavir; Giniflavir; Klion; Klont; Meronidal; Methronidazole; Metric; MetroCream; MetroGel; MetroLotion; Metrodzhil; Metrogyl; Metrolag; Metrolyl; Metromidol; Metronidaz; Metronidazol; Metronidazolo; Metronidazolum; Metrotop; Metrozine; Metryl; Mexibol; Monagyl; Monasin; NIDA; Nalox; Nidagel; Noritate; Novonidazol; Orvagil; Protostat; Rathimed; Rosased; Sanatrichom; Satric; Takimetol; Trichazol; Trichex; Trichocide; Trichomol; Trichopal; Trichopol; Tricocet; Tricom; Trikacide; Trikamon; Trikojol; Trikozol; Trimeks; Trivazol; Vagilen; Vagimid; Vandazole; Vertisal; Wagitran; Zadstat; Zidoval; Flagyl Er; Ginefla vir; METRONIDAZOLE USP; Metro Cream; Metro Gel; Metronidazole Monohydrochloride; Metronidazole Phosphoester; Metronidazole in Plastic Container; Metronidazolo [DCIT]; Tricho cordes; Trichomonacid pharmachim; Tricowas B; Bayer 5360; Flagyl 375; M0924; Metric 21; RP 8823; SC 10295; Anabact (TN); Apo-Metronidazole; Deflamon-wirkstoff; Flagyl (TN); IDR-90105; METRO I.V; MetroGel (TN); MetroGel-Vaginal; Metronidazol [INN-Spanish]; Metronidazolum [INN-Latin]; Mexibol (silanes); Neo-Tric; Noritate (TN); RP-8823; Rozex (TN); Tricho-gynaedron; ZERO/004064; CB-01-14 MMX; FLAGYL I.V. RTU IN PLASTIC CONTAINER; Flagyl I.V.; Flagyl I.V. RTU; Metro I.V.; Metro I.V. In Plastic Container; Metrogel-vaginal (TN); Metronidazole (JP15/USP/INN); Metronidazole [USAN:INN:BAN:JAN]; Methyl-5-nitroimidazole-1-ethanol; 1-Hydroxyethyl-2-methyl-5-nitroimidazole; 2-(2-methyl-5-nitroimidazol-1-yl)ethanol; 2-Methyl-5-nitro-1-imidazoleethanol; 2-Methyl-5-nitroimidazole-1-ethanol; MNZ
    Click to Show/Hide
External Link
CID: 4173
TTD: D0A2ZX
DrugBank: DB00916
 Compound Name Mercaptopurine Phase 4 [8]
Synonyms
6-mercaptopurine; Ismipur; Leukerin; Leupurin; Mercaleukim; Mercaleukin; Mercaptopurin; Mercaptopurina; Mercaptopurinum; Mercapurin; Merkaptopuryna; Mern; Purimethol; Purinethiol; Purinethol; Thiopurine; Leupu rin; Mercaptopurin [German]; Mercaptopurina Wellcome; Mercaptopurine anhydrous; Merkaptopuryna [Polish]; Puri Nethol; BW 57 323H; Glaxo Wellcome Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; M0063; NCIMech_000025; PM6; Wellcome Brand of 6 Mercaptopurine; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Mercaptopurina [INN-Spanish]; Mercaptopurine (INN); Mercaptopurine (VAN); Mercaptopurine (anhydrous); Mercaptopurinum [INN-Latin]; Puri-Nethol; Purineantimetabolite: inhibits nucleic acid replication; Purinethol (TN); U-4748; Wellcome Brand of 6-Mercaptopurine; AG-670/31547064; Purine-6-thiol; Leukerin, 99%-Carc; Purine-6(1H)-thione; Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine; 6 MP; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; 6 Thiopurine; 6-MERCAPTOPURINE MONOHYDRATE; 6-MP; 6-Mercaptopurin; 6-Merkaptopurin; 6-Merkaptopurin [Czech]; 6-Purinethiol; 6-Thiohypoxanthine; 6-Thiopurine; 6-Thioxopurine; Mercaptopurine (Purine analog)
    Click to Show/Hide
External Link
CID: 667490
TTD: D09UZO
DrugBank: DB01033
 Compound Name Upadacitinib Approved [9]
Synonyms
ABT-494
    Click to Show/Hide
External Link
CID: 58557659
TTD: D07JAG
DrugBank: DB15091
 Compound Name Plecanatide Phase 3 [10]
Synonyms
Trulance
    Click to Show/Hide
External Link
CID: 70693500
TTD: D07FEC
DrugBank: DB13170
 Compound Name Ozanimod Phase 3 [9]
Synonyms
1306760-87-1; Ozanimod (RPC1063); UNII-Z80293URPV; Z80293URPV; (S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile; Ozanimod [USAN:INN]; Ozanimod (USAN/INN); SCHEMBL2195490; GTPL8709; CHEMBL3707247; 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile; EX-A1316; s7952; ZINC116109867; AKOS026674086; DB12612; CS-5070; HY-12288; AC-29883; Benzonitrile, 5-(3-((1
    Click to Show/Hide
External Link
CID: 52938427
TTD: D07EDB
DrugBank: DB12612
 Compound Name Ritlecitinib Approved [9]
Synonyms
CBRJPFGIXUFMTM-WDEREUQCSA-N; 1792180-81-4; UNII-2OYE00PC25; 2OYE00PC25; PF06651600; 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one; GTPL9559; SCHEMBL16764638; BCP24778; EX-A2613; ZINC526061581; example 5 [WO2015083028]; ACN-040697; compound 11 [PMID: 28139931]; HY-100754; CS-0020243; 1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one malonate; 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
    Click to Show/Hide
External Link
CID: 118115473
TTD: D02TUL
DrugBank: DB14924
 Compound Name Citric acid, magnesium oxide, sodium picosulfate Approved [11]
Synonyms
Prepopik (TN)
    Click to Show/Hide
External Link
CID: 68654
TTD: D00TGR
 Compound Name PB006 Phase 3 [12]
Synonyms
Natalizumab Biosimilar
    Click to Show/Hide
External Link
TTD: DWKI46
 Compound Name Alofisel Phase 3 [13]
External Link
TTD: DV29RW
 Compound Name Brazikumab Phase 3 [14]
External Link
TTD: DMS12U
 Compound Name SHR0302 Phase 3 [15]
Synonyms
(3AR,5S,6AS)-N-(3-METHOXY-1,2,4-THIADIAZOL-5-YL)-5-(METHYL (7H-PYRROLO(2,3- D)PYRIMIDIN-4-YL)AMINO) HEXAHYDROCYCLOPENTA(C)PYRROLE-2(1H)-CARBOXAMIDE; (3aR,5s,6aS)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl (7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino) hexahydrocyclopenta(c)pyrrole-2(1H)-carboxamide; (3aR,6aS)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide; (3aS,6aR)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide; 1445987-21-2; AC-36766; AKOS040759719; CHEMBL5095398; CS-0062969; CYCLOPENTA(C)PYRROLE-2(1H)-CARBOXAMIDE, HEXAHYDRO-N-(3-METHOXY-1,2,4- THIADIAZOL-5-YL)-5-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-, (3A.ALPHA.,5.ALPHA.,6A.ALPHA.)-; Cyclopenta(c)pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-, (3aalpha,5alpha,6aalpha)-; EX-A5101; example 34 [WO2013091539A1]; F82248; GTPL11878; HY-112724; Ivarmacitinib; IVARMACITINIB [INN]; Ivarmacitinib [USAN]; K6K4B9Z5TV; MS-27180; NCGC00687790-01; rel-(3aR,5s,6aS)-N-(3-Methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxamide; SCHEMBL15077696; SCHEMBL15077710; SCHEMBL16191633; SHR0302; SHR-0302; SHR0302 base; SHR0302 FREE BASE; SHR-0302 FREE BASE; UNII-K6K4B9Z5TV; US9527851, 34; US9527851, 74; WHO 11823
    Click to Show/Hide
External Link
CID: 71622431
TTD: DFK8Z5
 Compound Name Remestemcel-L Phase 3 [16]
Synonyms
MSC-100-IV
    Click to Show/Hide
External Link
TTD: D1U5BA
 Compound Name Entyvio Phase 3 [9]
External Link
TTD: D0Y9GF
 Compound Name GS-5745 Phase 3 [9]
External Link
CID: 56776542
TTD: D0WL0Q
 Compound Name RHB-104 Phase 3 [9]
External Link
TTD: D0V1FP
 Compound Name Etrolizumab Phase 3 [9]
External Link
TTD: D0UH7R
 Compound Name Alicaforsen Phase 3 [17]
Synonyms
Alicaforsen [INN]; ISIS 2302; ISIS-2302; Intercellular adhesion molecule-1 antisense oligodeoxynucleotide; DNA, d((R)-P-thio)(G-C-C-A-A-G-C-T-G-G-C-A-T-C-C-G-T-C-A); Deoxyribonucleic acid, d((R)-P-thio)(G-C-C-C-A-A-G-C-T-G-G-C-A-T-C-C-G-T-C-A)
    Click to Show/Hide
External Link
CID: 16197725
TTD: D0P9BT
 Compound Name AJM-300 Phase 3 [18]
Synonyms
Alpha-4 integrin antagonist (inflammatory bowel disease), Ajinomoto
    Click to Show/Hide
External Link
TTD: D0M1WU
 Compound Name Vercirnon Phase 3 [19]
External Link
CID: 10343454
TTD: D0K3UQ
DrugBank: DB15250
 Compound Name ABT-874 Discontinued in Phase 2 [20]
External Link
TTD: D0H1TL
 Compound Name Sivelestat Application submitted [9]
Synonyms
127373-66-4; UNII-DWI62G0P59; 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid; Elastase Inhibitor IV; C20H22N2O7S; N-(2-(4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid; Sivelestat (ONO-5046); LY544349; CHEMBL76688; LY 544349; DWI62G0P59; Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-; N-(o-(p-Pivaloyloxybenzene)sulfonylaminobenzoyl)glycine
    Click to Show/Hide
External Link
CID: 107706
TTD: D0FT4R
DrugBank: DB12863
 Compound Name SB2 Application submitted [9]
Synonyms
Antimony; 7440-36-0; Stibium metallicum; Antimony, metallic; UNII-9IT35J3UV3; Antymonowodor [Polish]; UNII-0VKZ97K3UB; 0VKZ97K3UB; Antimonwasserstoffes [German]; HSDB 785; 9IT35J3UV3; UN2676; Antymon; Antimonio; Antimoine; Antimony powder; MFCD00011211; Antimonyl citrate; Antimony, ion(Sb2+); Sb2+; stibanylidyne; Antimonide; Antymonowodor; Antimon; antimony atom; Antimony, citric acid complexes; antimony(0); Antimonwasserstoffes; EINECS 270-130-2; ANTIMONOUS HYDRIDE; ACMC-1BKT5; 51Sb; EC 231-146-5; AC1NS5Q0; Sb(0); ANT
    Click to Show/Hide
External Link
CID: 5354495
TTD: D0CU1T
DrugBank: DB13110
 Compound Name Rifaximin DR Phase 3 [9]
External Link
TTD: D0AJ5E
 Compound Name BI 655066 Phase 2 [9]
External Link
TTD: D0A0MS
 Compound Name GED-0301 Phase 3 [9]
Synonyms
SMAD-7 inhibitor (oligonucleotide, Crohn's disease), Giuliani
    Click to Show/Hide
External Link
TTD: D09FKY
 Compound Name MSC-100-IV Phase 3 [9]
External Link
TTD: D07TSS
 Compound Name Prochymal Phase 3 [21]
External Link
TTD: D03KDO
 Compound Name SHP647 Phase 3 [9]
External Link
TTD: D02QWK
 Compound Name MORF-057 Phase 2 [22]
External Link
TTD: DYZA20
 Compound Name BI 706321 Phase 2 [23]
External Link
TTD: DRWI71
 Compound Name TEV-48574 Phase 2 [24]
External Link
TTD: D82MSU
 Compound Name EB8018 Phase 2 [25]
Synonyms
Sibofimloc; 1616113-45-1; Antibiotic-202; VRT-1353385; UNII-00OF00QZC4; 1-[2,7-Bis[2-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]ethynyl]spiro[fluorene-9,4'-piperidine]-1'-yl]ethanone; 1-[2,7-bis({2-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethynyl})spiro[fluorene-9,4'-piperidine]-1'-yl]ethan-1-one; 1-[2,7-bis[2-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethynyl]spiro[fluorene-9,4'-piperidine]-1'-yl]ethanone; Sibofimloc [INN]; Sibofimloc [USAN]; Sibofimloc (USAN/INN); CHEMBL4594305; SCHEMBL15836795; EX-A750; Antibiotic-202;VRT-1353385; MFCD28144726; WHO 10950; ZINC209678340; ACN-052475; CS-5487; DA-43714; HY-12820; B5896; D11825; J-690221; 1-(2,7-Bis(2,6-anhydro-7,8-dideoxy-D-glycero-D-manno-oct-7-ynitol-8-yl)spiro(fluorene-9,4'-piperidin)-1'-yl)ethan-1-one; 1-[2,7-bis[2-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethynyl]spiro[fluorene-9,4a?piperidine]-1a?yl]ethanone; 8,8'-(1'-Acetylspiro(9H-fluorene-9,4'-piperidine)-2,7-diyl)bis(2,6-anhydro-7,8-dideoxy-D-glycero-D-manno-oct-7-ynitol); D-Glycero-D-manno-oct-7-ynitol, 8,8'-(1'-acetylspiro(9H-fluorene-9,4'-piperidine)-2,7-diyl)bis(2,6-anhydro-7,8-dideoxy-
    Click to Show/Hide
External Link
CID: 76684239
TTD: D72HXF
 Compound Name PRA023 Phase 2 [26]
External Link
TTD: D61PGU
 Compound Name ABBV-154 Phase 2 [27]
External Link
TTD: D2AQW7
 Compound Name Alequel Phase 2 [9]
Synonyms
Antigens (colitis), Enzo; Antigen-specific immune regulation therapy (Crohn`s), Enzo
    Click to Show/Hide
External Link
TTD: D0XO7Q
 Compound Name YSIL6 Phase 2 [28]
External Link
TTD: D0VS2W
 Compound Name CC-1088 Phase 2 [29]
Synonyms
CDC801; CHEMBL88153; SCHEMBL185853; CDC-801; DDYUBCCTNHWSQM-UHFFFAOYSA-N; BDBM50216298; HY-U00179; CS-7247; 192819-27-5
    Click to Show/Hide
External Link
CID: 9844338
TTD: D0U2DH
 Compound Name GLPG-0634 Phase 2 [9]
Synonyms
Small molecule, JAK1/JAK2 inhibitor (rheumatoid arthritis), Galapagos/GSK
    Click to Show/Hide
External Link
CID: 49831257
TTD: D0SG7B
DrugBank: DB14845
 Compound Name Anti-IP10 Phase 2 [30]
External Link
TTD: D0L7LH
 Compound Name APD371 Phase 2 [31]
Synonyms
Olorinab; UNII-581F7DFA9B; 581F7DFA9B; Olorinab [USAN]; SCHEMBL11995430; 1268881-20-4; (4aS,5aS)-N-((2S)-1-hydroxy-3,3-dimethylbutan-2-yl)-1-(4-oxidopyrazin-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa(4,5)cyclopenta(1,2-c)pyrazole-3-carboxamide; 1H-Cyclopropa(4,5)cyclopenta(1,2-c)pyrazole-3-carboxamide, 4,4a,5,5a-tetrahydro-N-((1S)-1-(hydroxymethyl)-2,2-dimethylpropyl)-1-(4-oxido-2-pyrazinyl)-, (4aS,5aS)-; (1aS,5aS)-2-(4-Oxy-pyrazin-2-yl)-1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa(a)pentalene-4-carboxylic aci
    Click to Show/Hide
External Link
CID: 60164925
TTD: D0I4PW
DrugBank: DB14998
 Compound Name OPS-2071 Phase 2 [32]
External Link
TTD: D0GNF7
 Compound Name MEDI2070 Phase 2 [33]
External Link
TTD: D0F9XG
 Compound Name EGS-21 Phase 2 [34]
Synonyms
Glucocerebroside, Enzo; Glucosylceramide, Enzo Biochem
    Click to Show/Hide
External Link
CID: 6475228
TTD: D0D4ZW
 Compound Name GSK2330811 Phase 2 [35]
External Link
TTD: D0D3TQ
 Compound Name STA-5326 Phase 2 [36]
Synonyms
Apilimod; STA 5326; STA5326; N-[(3-methylphenyl)methylideneamino]-6-morpholin-4-yl-2-(2-pyridin-2-ylethoxy)pyrimidin-4-amine
    Click to Show/Hide
External Link
CID: 10173277
TTD: D0C9NJ
DrugBank: DB05611
 Compound Name MDX-1100 Phase 2 [37]
External Link
TTD: D0C1UF
 Compound Name PF-04236921 Phase 2 [9]
External Link
TTD: D06NXG
 Compound Name NN8555 Phase 2 [9]
External Link
TTD: D06JUE
 Compound Name AMG-181 Phase 2 [38]
Synonyms
Inflammatory bowel disease therapeutics, Amgen
    Click to Show/Hide
External Link
TTD: D04WQJ
 Compound Name SGX203 Phase 2 [9]
External Link
TTD: D04TFL
 Compound Name Clazakizumab Phase 2 [39]
External Link
TTD: D04RMM
 Compound Name MT-1303 Phase 2 [9]
External Link
CID: 67418070
TTD: D00ISN
 Compound Name EcoActive Phase 1/2 [40]
External Link
TTD: D1P8BK
 Compound Name AZD7798 Phase 1 [41]
External Link
TTD: DE3LH7
 Compound Name OSSM-001 Phase 1 [42]
External Link
TTD: DAD62Z
 Compound Name ONS-3010 Phase 1 [9]
External Link
TTD: D0MI8Z
 Compound Name ATR-107 Phase 1 [43]
Synonyms
PF-05230900
    Click to Show/Hide
External Link
TTD: D0M4MH
 Compound Name ChronsVax Phase 1 [9]
Synonyms
Crohn's disease vaccine; IR-777
    Click to Show/Hide
External Link
TTD: D0HJ5Y
 Compound Name C326 Phase 1 [44]
External Link
TTD: D0GJ1U
 Compound Name AMG-139 Phase 1 [45]
Synonyms
Anti-inflammatory agent (psoriasis, IBD), Amgen
    Click to Show/Hide
External Link
TTD: D0G3EU
 Compound Name TAK-828 Phase 1 [9]
Synonyms
ICMFYVOUDGRBLG-NJMNTPMDSA-N; TAK828F; GTPL9867; TAK-828F; SCHEMBL17390967; SCHEMBL17390969; SCHEMBL17391123; ICMFYVOUDGRBLG-VFHHBZAHSA-N; ICMFYVOUDGRBLG-XVNUGVHUSA-N; compound 10 [PMID: 29510038]; E3V; {cis-3-[(5R)-5-[(7-fluoro-1,1-dimethyl-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridine-6(5H)-carbonyl]cyclobutyl}acetic acid; (cis-3-(((5R)-5-((7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl)-2-methoxy-7,8-dihydro-1,6-naphthyridin-6 (5H)-yl)carbonyl)cyclobutyl)acetic acid; (cis-3-(((5R)-5-((7-fluoro-1,1-dimethyl-2
    Click to Show/Hide
External Link
CID: 118622692
TTD: D0D7CH
 Compound Name CrohnsVax Phase 1 [46]
External Link
TTD: D0CY2Q
 Compound Name ETX201 Phase 1 [9]
External Link
TTD: D09KIG
 Compound Name VBY-129 Phase 1 [9]
Synonyms
Cathepsin S inhibitor (oral, psoriasis), Virobay
    Click to Show/Hide
External Link
TTD: D07UKF
 Compound Name SAR252067 Phase 1 [47]
External Link
TTD: D06GAP
 Compound Name PF-06480605 Phase 1 [48]
External Link
TTD: D03IQD
 Compound Name ABBV-323 Phase 1 [9]
External Link
TTD: D01NZH
 Compound Name CCX-025 Phase 1 [49]
Synonyms
CCX-807; CCR9 chemokine receptor-targeting therapeutic (gastrointestinal diseases), ChemoCentryx
    Click to Show/Hide
External Link
TTD: D00YXU
 Compound Name Biaryl mannoside derivative 6 Patented [50]
Synonyms
PMID26651364-Compound-2f
    Click to Show/Hide
External Link
TTD: D0ZR2O
 Compound Name Biaryl mannoside derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-2c
    Click to Show/Hide
External Link
TTD: D0ZD6N
 Compound Name Alkyl mannoside derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-1b
    Click to Show/Hide
External Link
TTD: D0Z6PF
 Compound Name Mannoside derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-101
    Click to Show/Hide
External Link
TTD: D0Z1ZA
 Compound Name Biphenyl mannoside derivative 16 Patented [50]
Synonyms
PMID26651364-Compound-51
    Click to Show/Hide
External Link
TTD: D0Z1YF
 Compound Name PMID26651364-Compound-126b Patented [50]
External Link
TTD: D0YX4L
 Compound Name PMID26651364-Compound-7d Patented [50]
External Link
TTD: D0Y3UB
 Compound Name Aryl mannoside derivative 7 Patented [50]
Synonyms
PMID26651364-Compound-18
    Click to Show/Hide
External Link
TTD: D0Y0SI
 Compound Name Biaryl mannoside derivative 28 Patented [50]
Synonyms
PMID26651364-Compound-64
    Click to Show/Hide
External Link
TTD: D0XR1C
 Compound Name Mannoside derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-104
    Click to Show/Hide
External Link
TTD: D0XP5X
 Compound Name C-linked disaccharide biphenyl mannoside derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-88
    Click to Show/Hide
External Link
TTD: D0XH4K
 Compound Name Mannoside derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-103
    Click to Show/Hide
External Link
TTD: D0X8AB
 Compound Name PMID26651364-Compound-50 Patented [50]
External Link
TTD: D0X7HN
 Compound Name PMID26651364-Compound-118 Patented [50]
External Link
TTD: D0X4TV
 Compound Name Aryl mannoside derivative 18 Patented [50]
Synonyms
PMID26651364-Compound-80
    Click to Show/Hide
External Link
TTD: D0WW9B
 Compound Name Beta-cyclodextrin conjugate derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-133
    Click to Show/Hide
External Link
TTD: D0WV9J
 Compound Name PMID26651364-Compound-49 Patented [50]
External Link
TTD: D0WO6C
 Compound Name PMID26651364-Compound-111 Patented [50]
External Link
TTD: D0WO2I
 Compound Name Biphenyl mannoside derivative 20 Patented [50]
Synonyms
PMID26651364-Compound-55
    Click to Show/Hide
External Link
TTD: D0W7VE
 Compound Name PMID26651364-Compound-5b Patented [50]
External Link
TTD: D0W1SE
 Compound Name Biphenyl mannoside derivative 23 Patented [50]
Synonyms
PMID26651364-Compound-68b
    Click to Show/Hide
External Link
TTD: D0VG0F
 Compound Name PMID26651364-Compound-107 Patented [50]
External Link
TTD: D0VF5B
 Compound Name Aryl mannoside derivative 9 Patented [50]
Synonyms
PMID26651364-Compound-20
    Click to Show/Hide
External Link
TTD: D0VB4T
 Compound Name Alkyl mannoside derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-1a
    Click to Show/Hide
External Link
TTD: D0VA1D
 Compound Name PMID26651364-Compound-6d Patented [50]
External Link
TTD: D0UZ2S
 Compound Name C-linked disaccharide biphenyl mannoside derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-87
    Click to Show/Hide
External Link
TTD: D0US5I
 Compound Name PMID26651364-Compound-126a Patented [50]
External Link
TTD: D0UK1S
 Compound Name Biphenyl mannoside derivative 7 Patented [50]
Synonyms
PMID26651364-Compound-31
    Click to Show/Hide
External Link
TTD: D0UG9S
 Compound Name Biphenyl mannoside derivative 28 Patented [50]
Synonyms
PMID26651364-Compound-73
    Click to Show/Hide
External Link
TTD: D0UE3F
 Compound Name Alkyl mannoside derivative 6 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl04
    Click to Show/Hide
External Link
TTD: D0UB8U
 Compound Name Mannoside derivative 9 Patented [50]
Synonyms
PMID26651364-Compound-95
    Click to Show/Hide
External Link
TTD: D0TY1Q
 Compound Name PMID26651364-Compound-113 Patented [50]
External Link
TTD: D0TP8T
 Compound Name Aryl mannoside derivative 20 Patented [50]
Synonyms
PMID26651364-Compound-82
    Click to Show/Hide
External Link
TTD: D0T7VN
 Compound Name Biphenyl mannoside derivative 29 Patented [50]
Synonyms
PMID26651364-Compound-74
    Click to Show/Hide
External Link
TTD: D0T6NX
 Compound Name Biphenyl mannoside derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-25
    Click to Show/Hide
External Link
TTD: D0SU0E
 Compound Name PMID26651364-Compound-124 Patented [50]
External Link
TTD: D0SR8I
 Compound Name Alkyl mannoside derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl01
    Click to Show/Hide
External Link
TTD: D0SE7V
 Compound Name Aryl mannoside derivative 11 Patented [50]
Synonyms
PMID26651364-Compound-22
    Click to Show/Hide
External Link
TTD: D0SD4Q
 Compound Name Biphenyl mannoside derivative 17 Patented [50]
Synonyms
PMID26651364-Compound-52
    Click to Show/Hide
External Link
TTD: D0RZ5E
 Compound Name Biaryl mannoside derivative 22 Patented [50]
Synonyms
PMID26651364-Compound-44
    Click to Show/Hide
External Link
TTD: D0RG1Z
 Compound Name Biphenyl mannoside derivative 13 Patented [50]
Synonyms
PMID26651364-Compound-37
    Click to Show/Hide
External Link
TTD: D0RE0F
 Compound Name Mannoside derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-102
    Click to Show/Hide
External Link
TTD: D0R7YN
 Compound Name Aryl mannoside derivative 10 Patented [50]
Synonyms
PMID26651364-Compound-21
    Click to Show/Hide
External Link
TTD: D0R6FO
 Compound Name Biaryl mannoside derivative 29 Patented [50]
Synonyms
PMID26651364-Compound-65
    Click to Show/Hide
External Link
TTD: D0R2GA
 Compound Name Biaryl mannoside derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-2a
    Click to Show/Hide
External Link
TTD: D0R1SQ
 Compound Name Aryl mannoside derivative 16 Patented [50]
Synonyms
PMID26651364-Compound-78
    Click to Show/Hide
External Link
TTD: D0R1GD
 Compound Name PMID26651364-Compound-47 Patented [50]
External Link
TTD: D0QU6N
 Compound Name Beta-cyclodextrin conjugate derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-130
    Click to Show/Hide
External Link
TTD: D0QQ5W
 Compound Name PMID26651364-Compound-5f Patented [50]
External Link
TTD: D0QM2O
 Compound Name Biaryl mannoside derivative 23 Patented [50]
Synonyms
PMID26651364-Compound-59
    Click to Show/Hide
External Link
TTD: D0QL0X
 Compound Name Mannoside derivative 13 Patented [50]
Synonyms
PMID26651364-Compound-99
    Click to Show/Hide
External Link
TTD: D0Q7QK
 Compound Name PMID26651364-Compound-7e Patented [50]
External Link
TTD: D0Q1SX
 Compound Name PMID26651364-Compound-9c Patented [50]
External Link
TTD: D0Q0XC
 Compound Name PMID26651364-Compound-8d Patented [50]
External Link
TTD: D0P3SL
 Compound Name PMID26651364-Compound-11c Patented [50]
External Link
TTD: D0OW6O
 Compound Name Biaryl mannoside derivative 25 Patented [50]
Synonyms
PMID26651364-Compound-61
    Click to Show/Hide
External Link
TTD: D0OW1V
 Compound Name Mannoside derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-100
    Click to Show/Hide
External Link
TTD: D0OQ2R
 Compound Name PMID26651364-Compound-8c Patented [50]
External Link
TTD: D0O8EX
 Compound Name PMID26651364-Compound-10b Patented [50]
External Link
TTD: D0O4TC
 Compound Name Biphenyl mannoside derivative 8 Patented [50]
Synonyms
PMID26651364-Compound-32
    Click to Show/Hide
External Link
TTD: D0NB5P
 Compound Name PMID26651364-Compound-106 Patented [50]
External Link
TTD: D0N4WW
 Compound Name Biphenyl mannoside derivative 11 Patented [50]
Synonyms
PMID26651364-Compound-35
    Click to Show/Hide
External Link
TTD: D0N4TO
 Compound Name Biphenyl mannoside derivative 19 Patented [50]
Synonyms
PMID26651364-Compound-54
    Click to Show/Hide
External Link
TTD: D0N2AI
 Compound Name PMID26651364-Compound-10d Patented [50]
External Link
TTD: D0MZ8J
 Compound Name Alkyl mannoside derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl03
    Click to Show/Hide
External Link
TTD: D0MO0Z
 Compound Name Beta-cyclodextrin conjugate derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-129
    Click to Show/Hide
External Link
TTD: D0M7XB
 Compound Name PMID26651364-Compound-122 Patented [50]
External Link
TTD: D0LZ1W
 Compound Name PMID26651364-Compound-6c Patented [50]
External Link
TTD: D0L5OP
 Compound Name Aryl mannoside derivative 8 Patented [50]
Synonyms
PMID26651364-Compound-19
    Click to Show/Hide
External Link
TTD: D0L3JL
 Compound Name Biphenyl mannoside derivative 27 Patented [50]
Synonyms
PMID26651364-Compound-72
    Click to Show/Hide
External Link
TTD: D0L2QZ
 Compound Name Alkyl mannoside derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl02
    Click to Show/Hide
External Link
TTD: D0L1PO
 Compound Name Aryl mannoside derivative 6 Patented [50]
Synonyms
PMID26651364-Compound-17
    Click to Show/Hide
External Link
TTD: D0KX1A
 Compound Name PMID26651364-Compound-9b Patented [50]
External Link
TTD: D0KG5U
 Compound Name PMID26651364-Compound-46 Patented [50]
External Link
TTD: D0KE8Q
 Compound Name Biaryl mannoside derivative 27 Patented [50]
Synonyms
PMID26651364-Compound-63
    Click to Show/Hide
External Link
TTD: D0K7TE
 Compound Name PMID26651364-Compound-112 Patented [50]
External Link
TTD: D0K3DA
 Compound Name Biaryl mannoside derivative 11 Patented [50]
Synonyms
PMID26651364-Compound-3c
    Click to Show/Hide
External Link
TTD: D0K2AA
 Compound Name PMID26651364-Compound-127 Patented [50]
External Link
TTD: D0J8HJ
 Compound Name PMID26651364-Compound-4 Patented [50]
External Link
TTD: D0J0LC
 Compound Name PMID26651364-Compound-110 Patented [50]
External Link
TTD: D0IF4J
 Compound Name PMID26651364-Compound-117a Patented [50]
External Link
TTD: D0IB8D
 Compound Name PMID26651364-Compound-9f Patented [50]
External Link
TTD: D0I2MR
 Compound Name Biphenyl mannoside derivative 18 Patented [50]
Synonyms
PMID26651364-Compound-53
    Click to Show/Hide
External Link
TTD: D0HE3B
 Compound Name Mannoside derivative 11 Patented [50]
Synonyms
PMID26651364-Compound-97
    Click to Show/Hide
External Link
TTD: D0H7UR
 Compound Name C-linked disaccharide biphenyl mannoside derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-86
    Click to Show/Hide
External Link
TTD: D0H4CL
 Compound Name Biaryl mannoside derivative 19 Patented [50]
Synonyms
PMID26651364-Compound-41
    Click to Show/Hide
External Link
TTD: D0H1BZ
 Compound Name Biaryl mannoside derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-2b
    Click to Show/Hide
External Link
TTD: D0GV9F
 Compound Name Biphenyl mannoside derivative 22 Patented [50]
Synonyms
PMID26651364-Compound-68a
    Click to Show/Hide
External Link
TTD: D0GR3C
 Compound Name PMID26651364-Compound-115 Patented [50]
External Link
TTD: D0GP7L
 Compound Name Biphenyl mannoside derivative 9 Patented [50]
Synonyms
PMID26651364-Compound-33
    Click to Show/Hide
External Link
TTD: D0GM6O
 Compound Name PMID26651364-Compound-10a Patented [50]
External Link
TTD: D0GB6Y
 Compound Name Aryl mannoside derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-13
    Click to Show/Hide
External Link
TTD: D0G9KS
 Compound Name Aryl mannoside derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-14
    Click to Show/Hide
External Link
TTD: D0FT4P
 Compound Name PMID26651364-Compound-120 Patented [50]
External Link
TTD: D0FS9V
 Compound Name PMID26651364-Compound-6a Patented [50]
External Link
TTD: D0FL3H
 Compound Name Biaryl mannoside derivative 13 Patented [50]
Synonyms
PMID26651364-Compound-3e
    Click to Show/Hide
External Link
TTD: D0FI3Q
 Compound Name Mannoside derivative 6 Patented [50]
Synonyms
PMID26651364-Compound-92
    Click to Show/Hide
External Link
TTD: D0F6TN
 Compound Name Biaryl mannoside derivative 30 Patented [50]
Synonyms
PMID26651364-Compound-66
    Click to Show/Hide
External Link
TTD: D0ET9M
 Compound Name Biaryl mannoside derivative 14 Patented [50]
Synonyms
PMID26651364-Compound-3f
    Click to Show/Hide
External Link
TTD: D0EA9Y
 Compound Name Biphenyl mannoside derivative 15 Patented [50]
Synonyms
PMID26651364-Compound-39
    Click to Show/Hide
External Link
TTD: D0E9GD
 Compound Name Alkyl mannoside derivative 11 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-aryl02
    Click to Show/Hide
External Link
TTD: D0E3DS
 Compound Name PMID26651364-Compound-5g Patented [50]
External Link
TTD: D0E1GC
 Compound Name PMID26651364-Compound-6b Patented [50]
External Link
TTD: D0DW7A
 Compound Name Alkyl mannoside derivative 10 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-aryl01
    Click to Show/Hide
External Link
TTD: D0DI6U
 Compound Name Biaryl mannoside derivative 16 Patented [50]
Synonyms
PMID26651364-Compound-3h
    Click to Show/Hide
External Link
TTD: D0DI1T
 Compound Name Aryl mannoside derivative 12 Patented [50]
Synonyms
PMID26651364-Compound-23
    Click to Show/Hide
External Link
TTD: D0DH0Y
 Compound Name Aryl mannoside derivative 17 Patented [50]
Synonyms
PMID26651364-Compound-79
    Click to Show/Hide
External Link
TTD: D0D9MV
 Compound Name Alkyl mannoside derivative 7 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl05
    Click to Show/Hide
External Link
TTD: D0D6OM
 Compound Name Mannoside derivative 12 Patented [50]
Synonyms
PMID26651364-Compound-98
    Click to Show/Hide
External Link
TTD: D0D6HS
 Compound Name PMID26651364-Compound-117b Patented [50]
External Link
TTD: D0D2QE
 Compound Name Biphenyl mannoside derivative 26 Patented [50]
Synonyms
PMID26651364-Compound-71
    Click to Show/Hide
External Link
TTD: D0CR8J
 Compound Name PMID26651364-Compound-7c Patented [50]
External Link
TTD: D0CN7A
 Compound Name PMID26651364-Compound-5c Patented [50]
External Link
TTD: D0CN6Q
 Compound Name Beta-cyclodextrin conjugate derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-132
    Click to Show/Hide
External Link
TTD: D0CD7Q
 Compound Name PMID26651364-Compound-45 Patented [50]
External Link
TTD: D0C8EB
 Compound Name Biphenyl mannoside derivative 21 Patented [50]
Synonyms
PMID26651364-Compound-56
    Click to Show/Hide
External Link
TTD: D0BS3E
 Compound Name Biphenyl mannoside derivative 2 Patented [50]
Synonyms
PMID26651364-Compound-26
    Click to Show/Hide
External Link
TTD: D0BR9C
 Compound Name PMID26651364-Compound-8b Patented [50]
External Link
TTD: D0B9LM
 Compound Name Aryl mannoside derivative 14 Patented [50]
Synonyms
PMID26651364-Compound-76
    Click to Show/Hide
External Link
TTD: D0B8RU
 Compound Name C-linked disaccharide biphenyl mannoside derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-90
    Click to Show/Hide
External Link
TTD: D0B3CU
 Compound Name Biaryl mannoside derivative 20 Patented [50]
Synonyms
PMID26651364-Compound-42
    Click to Show/Hide
External Link
TTD: D0B1HT
 Compound Name PMID26651364-Compound-10c Patented [50]
External Link
TTD: D0AY0H
 Compound Name Aryl mannoside derivative 15 Patented [50]
Synonyms
PMID26651364-Compound-77
    Click to Show/Hide
External Link
TTD: D0AM0A
 Compound Name PMID26651364-Compound-7b Patented [50]
External Link
TTD: D0AK2Y
 Compound Name Biaryl mannoside derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-2d
    Click to Show/Hide
External Link
TTD: D0A8RV
 Compound Name PMID26651364-Compound-9e Patented [50]
External Link
TTD: D0A8GW
 Compound Name Biphenyl mannoside derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-28
    Click to Show/Hide
External Link
TTD: D0A3PP
 Compound Name Biphenyl mannoside derivative 24 Patented [50]
Synonyms
PMID26651364-Compound-69
    Click to Show/Hide
External Link
TTD: D09ZCA
 Compound Name Biaryl mannoside derivative 7 Patented [50]
Synonyms
PMID26651364-Compound-2g
    Click to Show/Hide
External Link
TTD: D09TKY
 Compound Name Aryl mannoside derivative 13 Patented [50]
Synonyms
PMID26651364-Compound-24
    Click to Show/Hide
External Link
TTD: D09SLI
 Compound Name Mannoside derivative 7 Patented [50]
Synonyms
PMID26651364-Compound-93
    Click to Show/Hide
External Link
TTD: D09LWZ
 Compound Name PMID26651364-Compound-105 Patented [50]
External Link
TTD: D09LWP
 Compound Name PMID26651364-Compound-5a Patented [50]
External Link
TTD: D09JDV
 Compound Name PMID26651364-Compound-8a Patented [50]
External Link
TTD: D09EXQ
 Compound Name Biaryl mannoside derivative 18 Patented [50]
Synonyms
PMID26651364-Compound-40
    Click to Show/Hide
External Link
TTD: D09EIQ
 Compound Name Aryl mannoside derivative 1 Patented [50]
Synonyms
PMID26651364-Compound-12
    Click to Show/Hide
External Link
TTD: D09BGB
 Compound Name PMID26651364-Compound-48 Patented [50]
External Link
TTD: D08WZC
 Compound Name Mannoside derivative 8 Patented [50]
Synonyms
PMID26651364-Compound-94
    Click to Show/Hide
External Link
TTD: D08OXD
 Compound Name Biaryl mannoside derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-2e
    Click to Show/Hide
External Link
TTD: D08BNB
 Compound Name Aryl mannoside derivative 23 Patented [50]
Synonyms
PMID26651364-Compound-85
    Click to Show/Hide
External Link
TTD: D08BLZ
 Compound Name Alkyl mannoside derivative 8 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl06
    Click to Show/Hide
External Link
TTD: D07RQA
 Compound Name PMID26651364-Compound-119 Patented [50]
External Link
TTD: D07RAA
 Compound Name Biaryl mannoside derivative 17 Patented [50]
Synonyms
PMID26651364-Compound-3i
    Click to Show/Hide
External Link
TTD: D07QAH
 Compound Name Aryl mannoside derivative 21 Patented [50]
Synonyms
PMID26651364-Compound-83
    Click to Show/Hide
External Link
TTD: D07PVX
 Compound Name Alkyl mannoside derivative 12 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-aryl03
    Click to Show/Hide
External Link
TTD: D07POS
 Compound Name Aryl mannoside derivative 22 Patented [50]
Synonyms
PMID26651364-Compound-84
    Click to Show/Hide
External Link
TTD: D07KCA
 Compound Name Alkyl mannoside derivative 9 Patented [50]
Synonyms
PMID26651364-Compound-Table2R1=n-alkyl07
    Click to Show/Hide
External Link
TTD: D07HOP
 Compound Name Biaryl mannoside derivative 12 Patented [50]
Synonyms
PMID26651364-Compound-3d
    Click to Show/Hide
External Link
TTD: D07GAN
 Compound Name Aryl mannoside derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-16
    Click to Show/Hide
External Link
TTD: D06SWT
 Compound Name Biaryl mannoside derivative 26 Patented [50]
Synonyms
PMID26651364-Compound-62
    Click to Show/Hide
External Link
TTD: D06PNN
 Compound Name PMID26651364-Compound-5e Patented [50]
External Link
TTD: D05ZHZ
 Compound Name PMID26651364-Compound-6e Patented [50]
External Link
TTD: D05XGH
 Compound Name Biphenyl mannoside derivative 14 Patented [50]
Synonyms
PMID26651364-Compound-38
    Click to Show/Hide
External Link
TTD: D05WWX
 Compound Name PMID26651364-Compound-11b Patented [50]
External Link
TTD: D05OMO
 Compound Name Biphenyl mannoside derivative 5 Patented [50]
Synonyms
PMID26651364-Compound-29
    Click to Show/Hide
External Link
TTD: D05JAS
 Compound Name PMID26651364-Compound-123 Patented [50]
External Link
TTD: D05HKC
 Compound Name PMID26651364-Compound-9a Patented [50]
External Link
TTD: D05CBP
 Compound Name Mannoside derivative 10 Patented [50]
Synonyms
PMID26651364-Compound-96
    Click to Show/Hide
External Link
TTD: D05BUD
 Compound Name PMID26651364-Compound-126c Patented [50]
External Link
TTD: D05BTL
 Compound Name Biphenyl mannoside derivative 30 Patented [50]
Synonyms
PMID26651364-Compound-75
    Click to Show/Hide
External Link
TTD: D05AZE
 Compound Name PMID26651364-Compound-125 Patented [50]
External Link
TTD: D04PKX
 Compound Name PMID26651364-Compound-128 Patented [50]
External Link
TTD: D04NXG
 Compound Name C-linked disaccharide biphenyl mannoside derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-89
    Click to Show/Hide
External Link
TTD: D03WXM
 Compound Name Biphenyl mannoside derivative 25 Patented [50]
Synonyms
PMID26651364-Compound-70
    Click to Show/Hide
External Link
TTD: D03WJB
 Compound Name Biphenyl mannoside derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-27
    Click to Show/Hide
External Link
TTD: D03RXE
 Compound Name Biphenyl mannoside derivative 12 Patented [50]
Synonyms
PMID26651364-Compound-36
    Click to Show/Hide
External Link
TTD: D03KAV
 Compound Name PMID26651364-Compound-108 Patented [50]
External Link
TTD: D03JFJ
 Compound Name Aryl mannoside derivative 4 Patented [50]
Synonyms
PMID26651364-Compound-15
    Click to Show/Hide
External Link
TTD: D03ITZ
 Compound Name PMID26651364-Compound-121 Patented [50]
External Link
TTD: D03HHG
 Compound Name Biphenyl mannoside derivative 10 Patented [50]
Synonyms
PMID26651364-Compound-34
    Click to Show/Hide
External Link
TTD: D03CTH
 Compound Name Biaryl mannoside derivative 15 Patented [50]
Synonyms
PMID26651364-Compound-3g
    Click to Show/Hide
External Link
TTD: D02ZYV
 Compound Name C-linked disaccharide biphenyl mannoside derivative 6 Patented [50]
Synonyms
PMID26651364-Compound-91
    Click to Show/Hide
External Link
TTD: D02XNH
 Compound Name Aryl mannoside derivative 19 Patented [50]
Synonyms
PMID26651364-Compound-81
    Click to Show/Hide
External Link
TTD: D02WWT
 Compound Name PMID26651364-Compound-9d Patented [50]
External Link
TTD: D02UDO
 Compound Name PMID26651364-Compound-7a Patented [50]
External Link
TTD: D02NDP
 Compound Name Biaryl mannoside derivative 9 Patented [50]
Synonyms
PMID26651364-Compound-3a
    Click to Show/Hide
External Link
TTD: D02HPF
 Compound Name Biaryl mannoside derivative 10 Patented [50]
Synonyms
PMID26651364-Compound-3b
    Click to Show/Hide
External Link
TTD: D02DFJ
 Compound Name Biaryl mannoside derivative 31 Patented [50]
Synonyms
PMID26651364-Compound-67
    Click to Show/Hide
External Link
TTD: D02AAD
 Compound Name Biaryl mannoside derivative 21 Patented [50]
Synonyms
PMID26651364-Compound-43
    Click to Show/Hide
External Link
TTD: D01ZKE
 Compound Name PMID26651364-Compound-5d Patented [50]
External Link
TTD: D01RHK
 Compound Name Biphenyl mannoside derivative 6 Patented [50]
Synonyms
PMID26651364-Compound-30
    Click to Show/Hide
External Link
TTD: D01PBX
 Compound Name PMID26651364-Compound-114 Patented [50]
External Link
TTD: D01CND
 Compound Name PMID26651364-Compound-109 Patented [50]
External Link
TTD: D00XKE
 Compound Name Beta-cyclodextrin conjugate derivative 3 Patented [50]
Synonyms
PMID26651364-Compound-131
    Click to Show/Hide
External Link
TTD: D00XEM
 Compound Name Biaryl mannoside derivative 8 Patented [50]
Synonyms
PMID26651364-Compound-2h
    Click to Show/Hide
External Link
TTD: D00RQW
 Compound Name PMID26651364-Compound-116 Patented [50]
External Link
TTD: D00RDO
 Compound Name PMID26651364-Compound-5 Patented [50]
External Link
TTD: D00KKD
 Compound Name Biaryl mannoside derivative 24 Patented [50]
Synonyms
PMID26651364-Compound-60
    Click to Show/Hide
External Link
TTD: D00COH
 Compound Name CDP571 Discontinued in Phase 3 [51]
External Link
TTD: D0S2GT
 Compound Name ISIS 104838 Discontinued in Phase 2 [52]
External Link
TTD: D0FX3P
 Compound Name TNFQb therapeutic vaccines Terminated [53]
Synonyms
TNFQb; CYT-020-TNFQb; TNF-targeted vaccine (inflammation, Immunodrug), Cytos Biotechnology; TNFQb therapeutic vaccines (rheumatoid arthritis/psoriasis/Crohn's disease); TNFQb therapeutic vaccines (rheumatoid arthritis/psoriasis/Crohn's disease), Cytos; Immunodrug vaccines (TNF) (rheumatoid arthritis/psoriasis/Crohn's disease), Cytos
    Click to Show/Hide
External Link
TTD: D06MJP
 Compound Name Mycophenolic acid Approved [6]
External Link
CID: 446541
TTD: D0Z8EV
DrugBank: DB01024
 Compound Name STP-432 Investigative [54]
Synonyms
Multi-targeted siRNA therapeutic (nanoparticle, Crohns disease), Sirnaomics
    Click to Show/Hide
External Link
TTD: D0QR8B
References
Ref 1 METTL3-mediated m(6) A modification of circPRKAR1B promotes Crohn's colitis by inducing pyroptosis via autophagy inhibition. Clin Transl Med. 2023 Sep;13(9):e1405. doi: 10.1002/ctm2.1405.
Ref 2 The Discovery of Novel Selective D1 Dopaminergic Agonists: A-68930, A-77636, A-86929, and ABT-413. International Journal of Medicinal Chemistry Volume 2011 (2011), Article ID 424535, Page(8).
Ref 3 FDA Approved Drug Products from FDA Official Website.
Ref 4 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019500.
Ref 5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7437).
Ref 6 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 7 ClinicalTrials.gov (NCT00509639) Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease. U.S. National Institutes of Health.
Ref 8 ClinicalTrials.gov (NCT00846703) The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia. U.S. National Institutes of Health.
Ref 9 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
Ref 10 The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication. Annu Rev Pharmacol Toxicol. 2014;54:9-26.
Ref 11 Nat Rev Drug Discov. 2013 Feb;12(2):87-90.
Ref 12 ClinicalTrials.gov (NCT04115488) Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri? in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS). U.S.National Institutes of Health.
Ref 13 ClinicalTrials.gov (NCT03706456) A Phase 3, Multicenter, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Cx601 in the Treatment of Complex Perianal Fistulas in Adult Patients With Crohn's Disease. U.S.National Institutes of Health.
Ref 14 ClinicalTrials.gov (NCT03961815) An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease (INTREPID OLE). U.S.National Institutes of Health.
Ref 15 ClinicalTrials.gov (NCT03677648) A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's Disease. U.S.National Institutes of Health.
Ref 16 ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health.
Ref 17 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
Ref 18 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019529)
Ref 19 ClinicalTrials.gov (NCT01536418) An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease. U.S. National Institutes of Health.
Ref 20 Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96. doi: 10.1517/14728214.13.1.175.
Ref 21 ClinicalTrials.gov (NCT00482092) Evaluation of PROCHYMAL Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health.
Ref 22 ClinicalTrials.gov (NCT05291689) A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Tolerability of MORF-057 in Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-1). U.S.National Institutes of Health.
Ref 23 ClinicalTrials.gov (NCT04978493) A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients With Crohn's Disease (CD) Receiving Ustekinumab Induction Treatment. U.S.National Institutes of Health.
Ref 24 ClinicalTrials.gov (NCT05668013) A 44-Week Phase 2b Long-Term Extension, RandomizEd, Double-BLind, Study to Determine the Long-Term PharmacokInetics, Efficacy, Safety, and Tolerability of TEV-48574 in Adult PatiEnts With Moderate to Severe Ulcerative Colitis or Crohn's Disease Who Completed the Main Phase of the Dose-Ranging Study (RELIEVE UCCD LTE). U.S.National Institutes of Health.
Ref 25 ClinicalTrials.gov (NCT03943446) TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD). U.S. National Institutes of Health.
Ref 26 ClinicalTrials.gov (NCT05013905) A Phase 2a, Multi-Center, Open-Label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease. U.S.National Institutes of Health.
Ref 27 ClinicalTrials.gov (NCT05068284) A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects With Moderately to Severely Active Crohn's Disease (CD): AIM-CD. U.S.National Institutes of Health.
Ref 28 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020380)
Ref 29 ClinicalTrials.gov (NCT00045786) Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes. U.S. National Institutes of Health.
Ref 30 ClinicalTrials.gov (NCT01466374) Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease. U.S. National Institutes of Health.
Ref 31 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
Ref 32 ClinicalTrials.gov (NCT03850509) Efficacy and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation. U.S. National Institutes of Health.
Ref 33 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031922)
Ref 34 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020751)
Ref 35 ClinicalTrials.gov (NCT04151225) Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease (COSMIS). U.S. National Institutes of Health.
Ref 36 A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis. 2006 Jul;12(7):558-65.
Ref 37 A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2012 Jun;64(6):1730-9. doi: 10.1002/art.34330. Epub 2011 Dec 6.
Ref 38 ClinicalTrials.gov (NCT01696396) AMG 181 in Subjects With Moderate to Severe Crohn's Disease. U.S. National Institutes of Health.
Ref 39 ClinicalTrials.gov (NCT02015520) Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis. U.S. National Institutes of Health.
Ref 40 ClinicalTrials.gov (NCT03808103) A Phase 1/2a Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Oral Administration of EcoActive on Intestinal Adherent Invasive Escherichia Coli (AIEC) in Patients With Inactive Crohn's Disease (CD). U.S.National Institutes of Health.
Ref 41 ClinicalTrials.gov (NCT05452304) A Phase 1 Randomised, Double-Blind, Placebo-Controlled 3 Part Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7798 Following Single Ascending Dose Administration and Repeat Dose Administration in Healthy Subjects (Including Japanese and Chinese Subjects), and Patients With Crohn's Disease. U.S.National Institutes of Health.
Ref 42 ClinicalTrials.gov (NCT05407766) A Phase I Safety Study of Allogeneic Bone Marrow Derived MSCs for Refractory Perianal Fistulizing Crohn's Disease. U.S.National Institutes of Health.
Ref 43 Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol. 2014 Jan;54(1):14-22.
Ref 44 ClinicalTrials.gov (NCT00353756) Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease. U.S. National Institutes of Health.
Ref 45 ClinicalTrials.gov (NCT01258205) Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects. U.S. National Institutes of Health.
Ref 46 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
Ref 47 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030237)
Ref 48 ClinicalTrials.gov (NCT01989143) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605in Healthy Subjects.. U.S. National Institutes of Health.
Ref 49 Clinical pipeline report, company report or official report of ChemoCentryx Inc.
Ref 50 Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease.Expert Opin Ther Pat. 2016;26(2):175-97.
Ref 51 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003884)
Ref 52 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013426)
Ref 53 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034853)
Ref 54 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.